Racial and ethnic differences in the utilization of autologous transplantation for lymphoma in the United States
Vaughn J, Soroka O, Epperla N, Safford M, Pinheiro L. Racial and ethnic differences in the utilization of autologous transplantation for lymphoma in the United States. Cancer Medicine 2021, 10: 7330-7338. PMID: 34469069, PMCID: PMC8525101, DOI: 10.1002/cam4.4249.Peer-Reviewed Original ResearchConceptsAutologous hematopoietic cell transplantationNon-Hispanic black patientsHematopoietic cell transplantationNon-Hispanic white patientsDisease-specific factorsBlack patientsWhite patientsLymphoma patientsNon-Hispanic black race/ethnicityEthnic disparitiesPopulation-based cohort studyBlack race/ethnicityCox proportional hazards modelEnd Results (SEER) dataNon-Hodgkin lymphomaPopulation-based dataProportional hazards modelEthnic differencesReceipt of transplantRace/ethnicityCohort studyPrimary outcomeAutologous transplantCell transplantationAutologous transplantationSurvival of patients with marginal zone lymphoma in the United States: A population‐based cohort study (2000 to 2017)
Vaughn J, Pinheiro L, Olszewski A, Epperla N. Survival of patients with marginal zone lymphoma in the United States: A population‐based cohort study (2000 to 2017). American Journal Of Hematology 2021, 96: e123-e126. PMID: 33476433, DOI: 10.1002/ajh.26103.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAged, 80 and overAntineoplastic Combined Chemotherapy ProtocolsCohort StudiesConfounding Factors, EpidemiologicFemaleHumansKaplan-Meier EstimateLymphoma, B-Cell, Marginal ZoneMaleMiddle AgedMortalityPrognosisRituximabSEER ProgramSocial Determinants of HealthUnited StatesYoung Adult